Bitcoin Price Can Hit $400,000, Brian Armstrong Says as CZ, Glassnode Hint at Upcoming Rally
Ceribell senior VP sells $224,451 of company stock By Investing.com

David Foehr, Senior VP, Finance and PAO at Ceribell, Inc. (), sold a total of $224,451 worth of company common stock on September 8, 2026. The shares were sold at prices ranging from $24.25 to $24.26. The timing of the sale comes after a remarkable run for the stock, which has delivered a 103% return over the past year and gained 27% in the last six months. According to InvestingPro analysis, the stock currently appears overvalued relative to its Fair Value, trading at a high Price/Book multiple of 7.01. Investors can access 11 additional InvestingPro Tips and comprehensive Fair Value analysis to better understand CBLL’s valuation.
Separately, Mr. Foehr acquired 7,500 shares of common stock by exercising stock options at a price of $4.70 per share, totaling $35,250. These transactions were executed under a Rule 10b5-1 trading plan established on May 21, 2026.
In other recent news, Ceribell Inc. reported second-quarter revenue of $28.1 million for fiscal 2026, marking a 33% increase from the previous year and a notable acceleration from the 29% growth observed in the first quarter. Despite this impressive revenue growth, the company posted a loss of $0.51 per share, which was wider than the $0.36 loss analysts had projected. Canaccord responded to these strong Q2 results by raising its price target for Ceribell shares to $26 from $25, while maintaining a Buy rating. Additionally, Raymond James increased its price target for Ceribell to $29, citing new growth drivers expected to enhance utilization and drive upside to consensus estimates. BTIG also raised its price target to $30, highlighting Ceribell’s leadership in point-of-care rapid EEG and its recent FDA approval for expanded indications. These developments reflect a positive growth outlook for Ceribell, with multiple firms maintaining a favorable stance on the company’s prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
